Drug
Aceclidine clinical trials
Also written LNZ100.
- studies test it
- 8
- open now
- 0
- in phase 3
- 4
- first study started
- 2022
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
8 studies that test it; most in 2023 (4)
| Year | Studies |
|---|---|
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 6
Often tested with
Tested in the same studies.
Brimonidine (7) · LNZ101 (1)
Studies
Open first, then newest update. How each study uses aceclidine is read from its arms, and is right about nine times in ten.
Testing it · 8
- Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of PresbyopiaCompletedPhase 3LENZ Therapeutics, IncNCT05728944Written as Aceclidine+Brimonidine combination ophthalmic solution
- Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of PresbyopiaCompletedPhase 3LENZ Therapeutics, IncNCT05656027Written as Aceclidine+Brimonidine combination ophthalmic solution
- Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia SubjectsCompletedPhase 3LENZ Therapeutics, IncNCT05753189Written as Aceclidine+Brimonidine combination ophthalmic solution
- Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the PresbyopiaCompletedPhase 3Corxel PharmaceuticalsNCT06045299Written as Aceclidine+Brimonidine combination ophthalmic solution
- Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of PresbyopiaCompletedPhase 2LENZ Therapeutics, IncNCT05431543Written as Aceclidine+Brimonidine combination ophthalmic solution
- Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of PresbyopiaCompletedPhase 2LENZ Therapeutics, IncNCT05294328Written as Aceclidine+Brimonidine combination ophthalmic solution
- Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With PresbyopiaCompletedPhase 1Corxel PharmaceuticalsNCT06270030Written as LNZ100 (Aceclidine) ophthalmic solution
- Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With PresbyopiaCompletedPhase 1LENZ Therapeutics, IncNCT05936489Written as Aceclidine + Brimonidine
As the comparator · 1 — what is tested is compared with aceclidine
Codes
What other systems call aceclidine · ClinicalTrials.gg INT003761
- MeSH (NLM) C084650aceclidineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0578K3ELIOACECLIDINEConfirmed FDA, NLM, Wikidata
- Wikidata Q2362603aceclidineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81044AceclidineOne source FDA
- DrugBank DB13262One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C084650 | aceclidine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0578K3ELIO | ACECLIDINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q2362603 | aceclidine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81044 | Aceclidine | One source FDA |
| DrugBank | DB13262 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.